Huffington Post: Resisting Resistance: What’s Next in the Fight Against Malaria?
Cameron Conaway, author

“It’s been described as a crisis in the anti-malaria community. Resistance to ACTs (artemisinin-based combination therapies), the oft-described super drug in efforts to combat malaria, have reached a tipping point. … Professor François Nosten, Director of the Shoklo Malaria Research Unit, has spent his career in Mae Sot, Thailand, the border area considered ground zero in this fight. If resistance continues, as it likely will, and if powerful new drugs are not able to counter the decline of ACTs, Professor Nosten fears malaria-related deaths could dramatically rise. … So what’s the alternative? Is there a promising new drug or combination of drugs on the horizon? I asked Professor Nicholas Day, director of the Mahidol Oxford Tropical Medicine Research Unit in Thailand…” A video interview accompanies the article (7/8).